02/07/2026

You've managed your skin for decades. You know what products work, what triggers a breakout, what your skin needs in winter. Then perimenopause starts, and the skin you knew becomes unpredictable: drier in some places, oilier in others, and increasingly marked by pigmentation you don't remember earning.

You've managed your skin for decades. You know what products work, what triggers a breakout, what your skin needs in winter. Then perimenopause starts, and the skin you knew becomes unpredictable: drier in some places, oilier in others, and increasingly marked by pigmentation you don't remember earning.

Dark patches that weren't there before. Spots that seem to appear faster than sun damage alone should produce. A generally uneven tone that no amount of brightening serum seems to touch.

This isn't ageing skin in the conventional sense. It's hormonal skin, and it responds to a different set of interventions.


Does Menopause Cause Pigmentation?

Yes, and the mechanism is well understood, even if it's under-discussed in most skincare contexts.

As oestrogen declines through perimenopause, several things happen simultaneously that drive pigmentation:

Melanocyte sensitivity increases. Oestrogen has a regulatory effect on melanocytes, the cells that produce pigment. As oestrogen falls, this regulation is removed, and melanocytes become more reactive to UV exposure, inflammation, and heat. The threshold for triggering melanin production drops.

Skin barrier function declines. Oestrogen plays a critical role in maintaining the skin barrier, supporting collagen production, hydration, and the lipid structure that keeps the skin intact. As oestrogen declines, the barrier becomes compromised, skin becomes more sensitive, and inflammatory signals reach melanocytes more readily.

Cortisol's relative influence increases. As sex hormone levels drop, cortisol, the stress hormone, exerts proportionally more influence on the skin. Cortisol triggers inflammation, which is one of the key drivers of pigmentation.

Cell turnover slows. In younger skin, melanin-containing cells are regularly shed from the surface through natural cell turnover, which clears some pigmentation passively. Slowing turnover means pigmentation persists on the surface longer.

The result: skin that produces more pigmentation in response to triggers that previously caused none, while losing the natural mechanisms that cleared it.


Why Menopause Pigmentation Is Different from Sun Damage

When most people think of age-related dark spots, they picture sun damage: discrete brown spots from cumulative UV exposure, often on the hands, chest and face. These are solar lentigines (liver spots), and they respond reasonably well to standard brightening treatments.

Menopause pigmentation is often a different pattern. It tends to be more diffuse: an uneven tone across the cheeks, forehead and upper lip rather than isolated spots. It may look like melasma (and in many cases is melasma, hormonally triggered by the oestrogen fluctuations of perimenopause). It often worsens in summer and improves slightly in winter. And critically, it tends to be more resistant to the brightening treatments that work on simple sun damage.

This resistance isn't mysterious. Because hormonal activation is driving the melanocytes, you can't simply clear the surface pigmentation and expect it to stay clear. As long as the hormonal signalling is active, new pigmentation continues to form. The treatment needs to address the melanin-production signal, not just the already-visible pigment.


The Hormonal Pigmentation Cycle in Perimenopause

Perimenopause, the years before the final menstrual period, is characterised by fluctuating oestrogen levels rather than a steady decline. Levels surge and drop unpredictably, sometimes over the course of days. This volatility is actually more destabilising for the skin than the steady lower levels of post-menopause.

Women in perimenopause often describe their pigmentation as variable: darker in some months than others, worse around certain times of the month when oestrogen surges. This reflects the melanocyte system responding to hormonal fluctuations in real time.

Post-menopause, oestrogen levels stabilise at a lower baseline. For some women, pigmentation stabilises too, though at a level higher than before perimenopause. The good news: treatment becomes more predictable once the hormonal volatility settles.


Can Menopause Pigmentation Be Treated Without HRT?

This question comes up frequently, particularly among women for whom HRT is not recommended or not desired. The short answer is yes.

HRT does not directly treat pigmentation. While restoring oestrogen levels may reduce the hormonal sensitivity driving melanocyte reactivity, it doesn't reverse existing pigmentation and introduces its own set of considerations. Many women on HRT still develop or maintain melasma. In fact, oestrogen in HRT can itself be a melanocyte trigger.

The more direct approach is to treat the five drivers of pigmentation at the skin level:

1. Melanin overproduction. Tyrosinase inhibitors, ingredients that slow the enzyme responsible for initiating melanin synthesis, work independently of hormonal status. The most effective non-hydroquinone options include azelaic acid, licorice root, tranexamic acid, niacinamide, and a range of botanical compounds with clinical evidence for tyrosinase inhibition.

2. Inflammation. Anti-inflammatory actives reduce the inflammatory signalling that reaches melanocytes. At the perimenopausal stage, this is a meaningful target: as the barrier weakens, inflammatory triggers are more frequent and the skin is less able to resolve them quickly.

3. Oxidative stress. UV-triggered oxidative stress is a major melanin activator. Antioxidants, including vitamin C, vitamin E, ferulic acid and plant-derived polyphenols, interrupt this process and help protect treatment progress.

4. Barrier disruption. Rebuilding and maintaining a strong barrier reduces melanocyte exposure to inflammatory signals and improves the skin's overall resilience to the environmental triggers that worsen pigmentation.

5. Hormonal activation. Ingredients that quiet the inflammatory melanocyte signal address the hormonal pathway directly, without requiring systemic intervention.

Melanin Reset is formulated around this five-pathway approach, including the hormonal activation of melanocytes that drives perimenopausal pigmentation specifically.


Why Radiance Recovery Crème Is Different

Most brightening treatments are designed for a stable skin environment: intact barrier, predictable penetration, non-hormonal triggers. Perimenopausal skin is none of those things. Melanin Reset was built for skin in hormonal transition: a formula designed not just for what the skin needs now, but for what it's dealing with at a systemic level.

Liposomal azelaic acid: effective through a compromised barrier. As oestrogen declines, so does barrier function, making perimenopausal skin simultaneously more sensitive and less able to consistently absorb topical treatments. Conventional azelaic acid requires an intact barrier to penetrate, and stings when it sits on sensitised surface skin. Melanin Reset encapsulates azelaic acid in liposomes: microscopic fat-based carriers with a structure that mirrors the cell membrane, allowing them to transport the active through barrier-compromised skin to the dermal-epidermal junction where melanocytes reside. Deeper delivery. Lower concentration. No surface stinging on skin that is already reactive. And the dual action of azelaic acid, tyrosinase inhibition and clinically demonstrated anti-inflammatory properties, makes it directly relevant to the two primary pigmentation pathways driving hormonal melasma.

Liposomal Tranexamic Acid: targeting the inflammatory pathway oestrogen used to suppress
Oestrogen has a natural anti-inflammatory effect on skin. As levels fall in perimenopause, that protection diminishes, leaving melanocytes more reactive to the UV-triggered and hormonal signals that instruct them to produce pigment. Tranexamic acid blocks the communication between keratinocytes and melanocytes: it inhibits plasminogen activator in the epidermis, reducing the prostaglandin signals that activate melanin synthesis in response to UV and inflammation. This makes it particularly well-suited to perimenopausal pigmentation, where the inflammatory threshold is lower and skin responds to triggers that wouldn’t have caused pigmentation a decade earlier. Standard topical tranexamic acid has limited depth of penetration. Radiance Recovery Crème delivers it in liposomes, lipid-encapsulated carriers that transport the active through the epidermis to the living layers where pigment production occurs, releasing it gradually to maximise effect and minimise surface reactivity.

Ayurvedic Adaptogens: Licorice and Amla Cellular Extracts. Licorice (glabridin) works at two levels for hormone-reactive skin: as a tyrosinase inhibitor slowing melanin production at source, and as an anti-inflammatory agent that quiets the signal reaching the melanocyte, without bleaching and without rebound. Amla (Indian gooseberry) compounds this with one of the richest natural vitamin C complexes of any plant, alongside polyphenols and tannins that inhibit melanin synthesis and shore up the antioxidant defences that oestrogen decline has reduced. In Ayurvedic tradition, amla is a rasayana, a compound that supports the body's adaptability to systemic change. For skin navigating the hormonal volatility of perimenopause, that isn't just philosophy; it's the formulation logic.


How Long Does It Take for Menopause Pigmentation to Respond to Treatment?

Perimenopausal pigmentation generally responds more slowly than post-inflammatory pigmentation or early-onset melasma, for the reasons described above. The ongoing hormonal signal means new pigmentation continues to form even as existing pigmentation is being addressed.

Realistic expectations:

  • Weeks 1–4: Skin tone may feel more even; surface brightness often improves first
  • Weeks 8–12: Visible fading of established patches begins in most users
  • Weeks 12–24: More significant fading of deeper, longer-standing pigmentation

Sun protection compliance is the single biggest variable in treatment speed. Each unprotected UV exposure activates the melanin system and undoes treatment progress. Physical (mineral) SPF 50+ applied every morning is the non-negotiable foundation of any treatment protocol.


Daily Routine for Menopause Skin with Pigmentation

Morning - Gentle, non-stripping cleanser - Melanin Reset applied to face and neck - Broad-spectrum mineral SPF 50+ - Wide-brimmed hat for outdoor time

Evening - Gentle cleanser - Melanin Reset applied to face and neck - Barrier-supporting moisturiser if needed

Avoid high-strength exfoliants during initial weeks of treatment: perimenopausal skin is often more sensitive than it was previously, and irritation risks triggering the post-inflammatory pigmentation cycle. Introduce additional actives slowly and separately.


The Bottom Line on Menopause Pigmentation

Pigmentation in perimenopause and menopause is not simply the result of sun exposure catching up with you. It's a hormonally driven shift in how your skin's melanin system responds to the world. Treating it effectively means addressing that system at the root, not just clearing the surface and hoping it stays clear.

The right approach targets melanin production, reduces inflammatory signalling, protects against oxidative stress, and rebuilds the barrier that's been compromised by oestrogen decline. With consistent treatment and rigorous sun protection, meaningful improvement is achievable, without HRT and without bleaching agents.


Melanin Reset targets five pigmentation pathways, including the hormonal activation driving perimenopausal and menopausal pigmentation. Formulated without hydroquinone or retinoids. Individual results vary. This article is for informational purposes and does not constitute medical advice.

02/07/2026

Leave a comment

Please note, comments need to be approved before they are published.